1. A Study on the Impact of Diabetes Mellitus on the Severity of COVID-19-Associated Mucormycosis
- Author
-
Siddharth Madan, Shelly Dutta, Rekha Yadav, Jolly Rohatgi, Ishita Bajaj, Nampi Tadu, Rahul Sharma, Gopal Krushna Das, Pramod Kumar Sahu, and Neelima Gupta
- Subjects
rocm ,covid-19 ,orbital mucormycosis ,diabetes mellitus ,corticosteroids ,General works ,R5-130.5 ,Science - Abstract
Objectives: Diabetes mellitus (DM) seems the most common predisposing factor for rhino-orbito-cerebral mucormycosis (ROCM). This study aimed to study the impact of DM on the severity of COVID-19-associated ROCM (CAM). Methods: This was a retrospective analytical study performed over a period of 3 months to assess the impact of DM on the severity of CAM in 100 patients and association of clinical correlates of DM with severity of CAM. Statistical analysis: The data collected using the study tools were converted into a computer-based spreadsheet and analyzed. The statistical analysis comprised a descriptive analysis that involved calculating means, standard deviations, and proportions. For calculating the significance of the difference of mean between two groups, Student's t-test was applied. In addition, chi-square test (or Fisher's t-test if applicable) was applied to study the significance of association of clinical correlates of DM with severity of CAM for categorical variables and t-test for continuous variables. Results: The prevalence of DM was 67%. The average presenting blood sugar level was 245.9 ± 99.86 mg%. Glycated hemoglobin level between 4.5 and 6.5% was observed in 57 patients and over 6.5% in 43 subjects. A high body mass index (BMI) of 25 and above was noted in 52 patients. A significantly higher level of presenting blood sugar and a longer duration of hospital stay was noted in patients having stage 3b or higher (p
- Published
- 2023
- Full Text
- View/download PDF